Delivery Order SPE2DB22D1106-SPE2DB25FEUN1
Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XCOPRI 100 mg tablets, a prescription medication. The contract has a ceiling value of $1,768.44 and a completion date of July 11, 2025. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,952.38 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,536.88 and a performance period ending on June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,420.16 and an ultimate completion date of July 2, 2025. It is a firm fixed-price contract, indicating the price is set and will not change. The contract is not designated as a set-aside, meaning it was open to all qualified...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 150-200 MG TITRATION PK UU 28S, a pharmaceutical product, with a ceiling value of $1,004.40. The contract has a firm fixed price pricing type and an ultimate completion date of June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,178.96, is for the delivery of XCOPRI 25 MG TABLET 30S, a medication. The contract is a Firm Fixed Price arrangement with a completion date of July 9, 2025. This order is not designated as a set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,899.85, is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,768.44, is for the delivery of XCOPRI 150 MG TABLET 30S, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,073.76 firm fixed-price contract is for the delivery of XCOPRI 50 MG TABLET 30S, a prescription medication, with a performance period ending on July 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,359.50 and a period of performance ending on July 9, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...